Physician

Gerald N Bock, MD

According to 2025 Medicare claims, Gerald Bock, MD (NPI: 1376649269) practices dermatology in the Stockton-Lodi, CA market, with the plurality of this provider's patient population coming from San Joaquin, CA. Bock uses personal NPI as billing NPI and primary practice location at 95207-6423.

Bock's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 628 traditional Medicare patients, billed 7,153 HCPCS/CPT codes, and received $424,750 in Medicare payments. The top billing code was 17004 (Destruction of precancer skin growth, 15 or more growths). Part D data shows 1,320 prescription claims across 383 beneficiaries totaling $259,615 in drug costs, led by Stelara (Ustekinumab). Open Payments data shows 3 records totaling $74. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $105,252 to $259,615. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$222K$444K2015 Medicare payment: $317,946 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $335,761 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $361,767 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $364,797 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $374,958 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $346,964 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $416,469 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $444,432 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $393,692 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $424,750 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156386,178$317,946
20166637,149$335,761
20177037,715$361,767
20187117,624$364,797
20197688,069$374,958
20206657,072$346,964
20217358,070$416,469
20227308,107$444,432
20236437,496$393,692
20246287,153$424,750

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$179K$359K2015 Drug cost: $105,252 (USD; Tot_Drug_Cst)2016 Drug cost: $98,443 (USD; Tot_Drug_Cst)2017 Drug cost: $61,966 (USD; Tot_Drug_Cst)2018 Drug cost: $54,799 (USD; Tot_Drug_Cst)2019 Drug cost: $49,069 (USD; Tot_Drug_Cst)2020 Drug cost: $155,607 (USD; Tot_Drug_Cst)2021 Drug cost: $165,263 (USD; Tot_Drug_Cst)2022 Drug cost: $179,926 (USD; Tot_Drug_Cst)2023 Drug cost: $358,941 (USD; Tot_Drug_Cst)2024 Drug cost: $259,615 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015308981$105,252
2016253860$98,443
2017240718$61,966
2018246738$54,799
2019271857$49,069
2020266920$155,607
20213361,098$165,263
20223471,158$179,926
20233481,123$358,941
20243831,320$259,615

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17004Destruction of precancer skin growth, 15 or more growths333506$132
11102Biopsy of related skin growth, first growth343490$75
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more4851,053$66
11103Biopsy of related skin growth, each additional growth223471$41
88305Pathology examination of tissue using a microscope, intermediate complexity3961,158$29

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
StelaraUstekinumab13364$185,725
OzempicSemaglutide24728$23,197
FluocinonideFluocinonide1103,649$5,824
Clobetasol PropionateClobetasol Propionate742,374$3,965
KetoconazoleKetoconazole1113,400$2,840

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$74GENZYME CORPORATION
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Gerald N. Bock, MD?

Tedicare shows public-source Medicare data for Gerald N. Bock, MD (NPI 1376649269), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gerald N. Bock, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Gerald N. Bock, MD?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Gerald N. Bock, MD have Open Payments data?

Gerald N. Bock, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.